Extending the Time for Thrombolysis in Emergency Neurological Deficits "EXTEND"

Recruiting

Phase 3 Results N/A

Summary of Purpose

The primary hypothesis being tested in this trial is that ischaemic stroke patients selected with significant penumbral mismatch (measured by MRI criteria) at 3 - 9 hours post onset of stroke will have improved clinical outcomes when given intravenous tissue plasminogen activator (tPA) compared to placebo.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 September 2016.

1 Jun 2010 22 Apr 2009 1 Dec 2017 1 Dec 2017 1 Sep 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts